Naslov
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

Autori
Devillier, Raynier ; Galimard, Jacques-Emmanuel ; Labopin, Myriam ; Blaise, Didier ; Raiola, Anna Maria ; Pavlu, Jiri ; Castagna, Luca ; Socié, Gerard ; Chalandon, Yves ; Martino, Massimo ; Stölzel, Friedrich ; Bug, Gesine ; Bruno, Benedetto ; Vrhovac, Radovan ; Charbonnier, Amandine ; Olivieri, Attilio ; Bay, Jacques-Olivier ; Arroyo, Herrera ; Yakoub-Agha, Ibrahim ; Avenoso, Daniele ; Neubauer, Andreas ; Nguyen, Stéphanie ; Forcade, Edouard ; Brissot, Eolia ; Savani, Bipin ; Nagler, Arnon ; Mohty, Mohamad

Izvornik
Bone marrow transplantation (Basingstoke) (0268-3369) 57 (2022); 1421-1427

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
reduced intensity ; non-myeloablative ; conditioning ; acute myeloid leukemia

Sažetak
The optimal conditioning regimen prior haploidentical stem cell transplantation (Haplo-SCT) with post transplantation cyclophosphamide (PT-Cy) for acute myeloid leukemia (AML) remains unknown. A non-myeloablative conditioning (NMAC) regimen (cyclophosphamide + fludarabine + TBI 2 Gy [CyFluTBI]) is a safe approach, but relapse incidence remains high in this setting. Alternatively, a reduced intensity conditioning (RIC) regimen combining thiotepa and reduced-dose busulfan with fludarabine (TBF) may decrease AML relapse. However, an excess of toxicity may counterbalance this potential benefit. We retrospectively compared CyFluTBI vs. TBF in CR AML patients who underwent Haplo-SCT with PT-Cy, in two different populations based on age. We analyzed 490 patients. In patients aged <60 years (n = 203), we observed a higher RI (HR = 3.59, 95% CI = 1.75–7.37, p < 0.01), lower LFS (HR = 1.98, 95% CI = 1.22–3.22, p < 0.01) and lower OS (HR = 1.73, 95% CI = 1.04– 2.88, p = 0.04) in the CyFluTBI group, without significant difference in NRM. In older patients (n = 287), we observed that conditioning regimen did not significantly influence LFS (HR = 0.90, 95% CI = 0.56–1.44, p = 0.65), OS (HR = 0.81, 95% CI = 0.49–1.32, p = 0.39) and RI (HR = 1.78, 95% CI = 0.90–3.50, p = 0.10), but showed that CyFluTBI was associated with a significantly lower risk of NRM (HR = 0.48, 95% CI = 0.25–0.92, p = 0.03). Thus, younger patients seem to benefit from conditioning intensification from CyFluTBI to TBF regimens prior PT-Cy Haplo-SCT for CR AML, while older ones do not.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA